Evidence map›Paper›PMID 29024374›Full record

Observational studyAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2018

Human papillomavirus and posttransplantation cutaneous squamous cell carcinoma: A multicenter, prospective cohort study.

Jan N Bouwes Bavinck, Mariet C W Feltkamp, Adele C Green, Marta Fiocco, Sylvie Euvrard, Catherine A Harwood, Shaaira Nasir, Jason Thomson, Charlotte M Proby, Luigi Naldi and 20 more

Open access · bronzeAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 83 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Compromised T Cell Immunity Links Increased Cutaneous Papillomavirus Activity to Squamous Cell Carcinoma Risk.JID innovations : skin science from molecules to population health · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 13 institutions in 6 countries.

Jan N Bouwes BavinckDepartment of Dermatology, Leiden University Medical Center, Leiden, The Netherlands.
Mariet C W FeltkampDepartment of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands.
Adele C GreenQIMR Berghofer Medical Research Institute, Brisbane, Australia.
Marta FioccoDepartment of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, The Netherlands.
Sylvie EuvrardDepartment of Dermatology, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France.
Catherine A HarwoodCentre for Cell Biology and Cutaneous Research, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, UK.
Shaaira NasirCentre for Cell Biology and Cutaneous Research, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, UK.
Jason ThomsonCentre for Cell Biology and Cutaneous Research, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, UK.
Charlotte M ProbyDivision of Cancer Research, University of Dundee, Ninewells Hospital and Medical School, Dundee, UK.
Luigi NaldiDepartment of Dermatology, Azienda Ospedaliera papa Giovanni XXIII, and GISED Study Center, Bergamo, Italy.
Janouk C D DiphoornDepartment of Dermatology, Azienda Ospedaliera papa Giovanni XXIII, and GISED Study Center, Bergamo, Italy.
Anna VenturuzzoDepartment of Dermatology, Azienda Ospedaliera papa Giovanni XXIII, and GISED Study Center, Bergamo, Italy.
Gianpaolo TessariDepartment of Medicine, Section of Dermatology, University of Verona, c/o Ospedale Civile Maggiore, Verona, Italy.
Ingo NindlDepartment of Dermatology, University Hospital Charité, Skin Cancer Center Charité, Berlin, Germany.
Francesca SampognaClinical Epidemiology Unit, IDI-IRCCS FLMM, Rome, Italy.
Damiano AbeniClinical Epidemiology Unit, IDI-IRCCS FLMM, Rome, Italy.
Rachel E NealeQIMR Berghofer Medical Research Institute, Brisbane, Australia.
Jelle J GoemanDepartment of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, The Netherlands.
Koen D QuintDepartment of Dermatology, Leiden University Medical Center, Leiden, The Netherlands.
Anne B HalkDepartment of Dermatology, Leiden University Medical Center, Leiden, The Netherlands.
Carmen SneekDepartment of Dermatology, Leiden University Medical Center, Leiden, The Netherlands.
Roel E GendersDepartment of Dermatology, Leiden University Medical Center, Leiden, The Netherlands.
Maurits N C de KoningDDL Diagnostic Laboratory, Rijswijk, The Netherlands.
Wim G V QuintDDL Diagnostic Laboratory, Rijswijk, The Netherlands.
Ulrike WielandInstitute of Virology, University of Cologne, Cologne, Germany.
Sönke WeissenbornInstitute of Virology, University of Cologne, Cologne, Germany.
Tim WaterboerGerman Cancer Research Center (DKFZ), Heidelberg, Germany.
Michael PawlitaGerman Cancer Research Center (DKFZ), Heidelberg, Germany.
Herbert PfisterInstitute of Virology, University of Cologne, Cologne, Germany.
EPI-HPV-UV-CA group
Leiden University Medical Center · NLCentro Studi GISED · ITQueen Mary University of London · GBUniversity of Cologne · DEDDL Diagnostic Laboratory · NLIstituti di Ricovero e Cura a Carattere Scientifico · ITQIMR Berghofer Medical Research Institute · AUCharité - Universitätsmedizin Berlin · DEGerman Cancer Research Center · DEHeidelberg University · DEHospices Civils de Lyon · FRNinewells Hospital · GBUniversity of Verona · IT

Funding

Medical Research Council G0802468
6 · The paper itself

Abstract

Organ transplant recipients (OTRs) have a 100-fold increased risk of cutaneous squamous cell carcinoma (cSCC). We prospectively evaluated the association between β genus human papillomaviruses (βPV) and keratinocyte carcinoma in OTRs. Two OTR cohorts without cSCC were assembled: cohort 1 was transplanted in 2003-2006 (n = 274) and cohort 2 was transplanted in 1986-2002 (n = 352). Participants were followed until death or cessation of follow-up in 2016. βPV infection was assessed in eyebrow hair by using polymerase chain reaction-based methods. βPV IgG seroresponses were determined with multiplex serology. A competing risk model with delayed entry was used to estimate cumulative incidence of histologically proven cSCC and the effect of βPV by using a multivariable Cox regression model. Results are reported as adjusted hazard ratios (HRs). OTRs with 5 or more different βPV types in eyebrow hair had 1.7 times the risk of cSCC vs OTRs with 0 to 4 different types (HR 1.7, 95% confidence interval 1.1-2.6). A similar risk was seen with high βPV loads (HR 1.8, 95% confidence interval 1.2-2.8). No significant associations were seen between serum antibodies and cSCC or between βPV and basal cell carcinoma. The diversity and load of βPV types in eyebrow hair are associated with cSCC risk in OTRs, providing evidence that βPV is associated with cSCC carcinogenesis and may present a target for future preventive strategies.

Indexed as

Antibodies, ViralCarcinoma, Squamous CellCase-Control StudiesDNA, ViralEyebrowsFemaleFollow-Up StudiesHumansMaleMiddle AgedOrgan TransplantationPapillomaviridaePapillomavirus InfectionsPrognosisProspective StudiesSkin NeoplasmsAntibodies, ViralDNA, Viralcancer/malignancy/neoplasia: risk factorscancer/malignancy/neoplasia: skin - nonmelanomaclinical research/practiceinfection and infectious agents - viralinfection and infectious agents - viral: papillomavirusorgan transplantation in general

Identifiers

PMID29024374
PMCPMC5947129
OpenAlexW2764189939

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.